|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 50 F Street, N.W. |
Address2 | suite 360 |
City | Washington |
State | DC |
Zip Code | 20001-1530 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 40036299-12
|
||||||||
|
6. House ID# 401600000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Stuart Spielman |
Date | 10/18/2023 4:12:25 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 485, Protecting Health Care for All Patients Act of 2023, all provisions
H.R. 547/S.100, Better Care Better Jobs Act, all provisions
H.R. 1267/S.545, Air Carrier Access Amendments Act of 2023, all provisions
H.R. 1445/S.400, Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023
H.R. 1493/S.762, HCBS Access Act, all provisions
H.R. 2401/S.1071, The Respond, Innovate, Succeed, and Empower (RISE) Act, all provisions
H.R. 2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, provisions related to study of TRICARE Autism Care Demonstration program and study on service by neurodivergent individuals in the Department of Defense
H.R. 2706/S.1183, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions
H.R. 2941/S.1332, Recognizing the Role of Direct Support Professionals Act, all provisions
H.R. 2965/S.1333, Autism Family Caregivers Act of 2023, all provisions
H.R. 3380, HEADs UP Act of 2023, all provisions
H.R. 3963/S.1377, Visitable Inclusive Tax Credits for Accessible Living (VITAL) Act, all provisions
H.R. 4049, Access and Dignity for All People who Travel (ADAPT) Act, all provisions
H.R. 4259, Think Differently about Education Act of 2023, all provisions
H.R. 4365/S.2587, Department of Defense Appropriations Act, 2024, provisions related to the congressionally directed medical research autism research program
H.R. 4519/S.2217, IDEA Full Funding Act, all provisions
H.R. 4550, The Preparing and Retaining All Educators Act (PARA Act), all provisions
H.R. 5408/S.2767, SSI Savings Penalty Elimination Act, all provisions
H.R. 5141, Funding Early Childhood is the Right IDEA Act, all provisions
S.400, Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, all provisions
S.1459, MOBILE Act, all provisions
S.1219, Health Equity for People with Disabilities Act, all provisions
S.1765, Emergency Vacating of Aircraft Cabin Act, all provisions
S.2196, Work Without Worry Act, all provisions
S.2321, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024, provisions related to funding for the Kevin and Avontes Law program
S.2522, ABLE MATCH (Making Able a Tool to Combat Hardship) Act, all provisions
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education
Implementation of P.L. 117-263, provision related to reauthorization of the Missing Americans Alert Program
Implementation of P.L. 117-328, Consolidated Appropriations Act, 2023, provisions related to funding for mental health research at the National Institute of Mental Health, autism and aging research at the National Institute on Aging, and funding for the Autism and Developmental Disabilities Monitoring Network
A bill not yet introduced to amend the Public Health Service Act to enhance activities of the National Institutes of Health with respect to research on autism spectrum disorder and enhance programs relating to autism, and for other purposes
A bill not yet introduced related to transition planning for autistic individuals
A bill not yet introduced to address food insecurity among autistic individuals and their families
A bill not yet introduced related to Fiscal Year 2024 appropriations by the House, provisions related to funding autism research and services at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration; assistive technology programs and special education at the Department of Education; and funding for the Kevin and Avonte's Law program
Advocacy with the Department of Education related to improving transition services for autistic students
Advocacy with the White House Office of Science and Technology Policy related to services for autistic people with mental health issues
Advocacy with the Food and Drug Administration related to electrical stimulation devices
Advocacy with the Department of Health and Human Services and the National Institutes of Health to designate people with disabilities a health disparity population
Advocacy with the Centers for Medicare and Medicaid Services to support caregiver training services in the Calendar Year 2024 Medicare Physician Fee Schedule
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Natl Institute of Mental Health (NIMH), Food & Drug Administration (FDA), Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stuart |
Spielman |
|
|
|
David |
Sitcovsky |
|
|
|
Chrissy |
Raymond |
|
|
|
Alyssa |
Brockington |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |